Contact Us for our BEST PRICE Now! +44 7887 945 155 Email Us
Follow RSS for latest reports on this topicPricing - Market Research and Reports
The pricing of drugs and healthcare is highly political with differing reimbursement and charging systems.
BioPortfolio's Easy Ordering System
- Search for the report you need from our store
- Make online payment with our easy checkout process
- Receive PDF report via email
Easy Online Payment or Pro Forma Invoice
We accept the following credit cards...
or can supply a pro-forma invoice if required.
Related Reports:
We found over 40 reports that matched your search.
Next 40 Matches >Refine your search, and find more matches, using the form above.
Pruritus - Pricing & Market Access and Landscape- 2019
Firstview Insight's Pruritus - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Pruritus based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment ...Read More >>>
Published:
2019-12-27
Published by: First View Insight
Prices Starting From:
$2125
Tularaemia - Pricing & Market Access and Landscape- 2019
Firstview Insight's Tularaemia - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Tularaemia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatm...Read More >>>
Published:
2019-12-27
Published by: First View Insight
Prices Starting From:
$2125
Vaginitis - Pricing & Market Access and Landscape- 2019
Firstview Insight's Vaginitis - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Vaginitis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatmen...Read More >>>
Published:
2019-12-27
Published by: First View Insight
Prices Starting From:
$2125
Pharyngitis - Pricing & Market Access and Landscape- 2019
Firstview Insight's Pharyngitis - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Pharyngitis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current trea...Read More >>>
Published:
2019-12-27
Published by: First View Insight
Prices Starting From:
$2125
Seizures - Pricing & Market Access and Landscape- 2036
Firstview Insight's Seizures - Pricing & Market Access and Landscape- 2036 provides country specific insights in order to estimate market potential for Seizures based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment ...Read More >>>
Published:
2019-12-27
Published by: First View Insight
Prices Starting From:
$2125
Sinusitis - Pricing & Market Access and Landscape- 2040
Firstview Insight's Sinusitis - Pricing & Market Access and Landscape- 2040 provides country specific insights in order to estimate market potential for Sinusitis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatmen...Read More >>>
Published:
2019-12-27
Published by: First View Insight
Prices Starting From:
$2125
Syphilis - Pricing & Market Access and Landscape- 2045
Firstview Insight's Syphilis - Pricing & Market Access and Landscape- 2045 provides country specific insights in order to estimate market potential for Syphilis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment ...Read More >>>
Published:
2019-12-27
Published by: First View Insight
Prices Starting From:
$2125
Wet AMD - Pricing & Market Access and Landscape- 2019
Firstview Insight's Wet AMD - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Wet AMD based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment para...Read More >>>
Published:
2019-12-20
Published by: First View Insight
Prices Starting From:
$2125
Adrenoleukodystrophy - Pricing & Market Access and Landscape- 2019
Firstview Insight's Adrenoleukodystrophy - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Adrenoleukodystrophy based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing i...Read More >>>
Published:
2019-12-08
Published by: First View Insight
Prices Starting From:
$2125
AlphaMannosidosis - Pricing & Market Access and Landscape- 2019
Firstview Insight's AlphaMannosidosis - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for AlphaMannosidosis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the ...Read More >>>
Published:
2019-12-08
Published by: First View Insight
Prices Starting From:
$2125
Astrocytoma - Pricing & Market Access and Landscape- 2019
Firstview Insight's Astrocytoma - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Astrocytoma based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current trea...Read More >>>
Published:
2019-12-08
Published by: First View Insight
Prices Starting From:
$2125
Cachexia - Pricing & Market Access and Landscape- 2019
Firstview Insight's Cachexia - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Cachexia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment pa...Read More >>>
Published:
2019-12-08
Published by: First View Insight
Prices Starting From:
$2125
Cardiomyopathy - Pricing & Market Access and Landscape- 2019
Firstview Insight's Cardiomyopathy - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Cardiomyopathy based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the curren...Read More >>>
Published:
2019-12-08
Published by: First View Insight
Prices Starting From:
$2125
Allergic Conjunctivitis - Pricing and Market Access
Firstview Insight's Allergic Conjunctivitis - Pricing and Market Access provides country specific insights in order to estimate market potential for Allergic Conjunctivitis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the curren...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Alopecia Areata - Pricing and Market Access
Firstview Insight's Alopecia Areata - Pricing and Market Access provides country specific insights in order to estimate market potential for Alopecia Areata based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradi...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Alpha Thalassemia - Pricing and Market Access
Firstview Insight's Alpha Thalassemia - Pricing and Market Access provides country specific insights in order to estimate market potential for Alpha Thalassemia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment ...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Amyloidosis - Pricing and Market Access
Firstview Insight's Amyloidosis - Pricing and Market Access provides country specific insights in order to estimate market potential for Amyloidosis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradigmThus...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Anal Cancer - Pricing and Market Access
Firstview Insight's Anal Cancer - Pricing and Market Access provides country specific insights in order to estimate market potential for Anal Cancer based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradigmThus...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Anaplastic Astrocytoma - Pricing and Market Access
Firstview Insight's Anaplastic Astrocytoma - Pricing and Market Access provides country specific insights in order to estimate market potential for Anaplastic Astrocytoma based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current ...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Atopic Dermatitis - Pricing and Market Access
Firstview Insight's Atopic Dermatitis - Pricing and Market Access provides country specific insights in order to estimate market potential for Atopic Dermatitis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment pa...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Behcets Disease - Pricing and Market Access
Firstview Insight's Behcets Disease - Pricing and Market Access provides country specific insights in order to estimate market potential for Behcets Disease based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment para...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Beta Thalassemia - Pricing and Market Access
Firstview Insight's Beta Thalassemia - Pricing and Market Access provides country specific insights in order to estimate market potential for Beta Thalassemia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment pa...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Bipolar Disorder - Pricing and Market Access
Firstview Insight's Bipolar Disorder - Pricing and Market Access provides country specific insights in order to estimate market potential for Bipolar Disorder based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment para...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Bronchopulmonary Dysplasia - Pricing and Market Access
Firstview Insight's Bronchopulmonary Dysplasia - Pricing and Market Access provides country specific insights in order to estimate market potential for Bronchopulmonary Dysplasia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the ...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Colorectal cancer - Pricing and Market Access
Firstview Insight's Colorectal cancer - Pricing and Market Access provides country specific insights in order to estimate market potential for Colorectal cancer based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment pa...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Cystic fibrosis - Pricing and Market Access
Firstview Insight's Cystic fibrosis - Pricing and Market Access provides country specific insights in order to estimate market potential for Cystic fibrosis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment para...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Ewing Sarcoma - Pricing and Market Access
Firstview Insight's Ewing Sarcoma - Pricing and Market Access provides country specific insights in order to estimate market potential for Ewing Sarcoma based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradigm...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Myelodysplastic Syndrome - Pricing and Market Access
Firstview Insight's Myelodysplastic Syndrome - Pricing and Market Access provides country specific insights in order to estimate market potential for Myelodysplastic Syndrome based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the curr...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Keratoconjunctivitis sicca (Dry Eye) - Pricing and Market Access
Firstview Insight's Latestage chronic kidney disease (CKD) - Pricing and Market Access provides country specific insights in order to estimate market potential for Latestage chronic kidney disease (CKD) based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stake...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Liver cancer - Pricing and Market Access
Firstview Insight's Macular Edema - Pricing and Market Access provides country specific insights in order to estimate market potential for Macular Edema based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradigm...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Macular Edema - Pricing and Market Access
Firstview Insight's Major depressive disorder - Pricing and Market Access provides country specific insights in order to estimate market potential for Major depressive disorder based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the curr...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Medullary Thyroid Cancer - Pricing and Market Access
Firstview Insight's Medulloblastoma - Pricing and Market Access provides country specific insights in order to estimate market potential for Medulloblastoma based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment pa...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Medulloblastoma - Pricing and Market Access
Firstview Insight's Merkel Cell Carcinoma - Pricing and Market Access provides country specific insights in order to estimate market potential for Merkel Cell Carcinoma based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current trea...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Merkel Cell Carcinoma - Pricing and Market Access
Firstview Insight's Merkel Cell Carcinoma - Pricing and Market Access provides country specific insights in order to estimate market potential for Merkel Cell Carcinoma based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current trea...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Pricing and Reimbursement in Oncology -- Payer views
As payer and stakeholder anger mounts, when will the oncology drug price bubble burst? Global cancer drug prices have increased by 10% every year between 1995 and 2013. That level of price inflation is not sustainable or winning pharma any friends. In this expert report, US and EU payers note that monopolistic pricing for novel products that represent the only therapeutic option, or the high price...Read More >>>
Published:
2018-01-01
Published by: FirstWord Pharma
Prices Starting From:
$2019
Pricing and Reimbursement in Neurology -- Payer views
When first line treatments for neurological diseases such as Parkinson's Disease (PD) and Multiple Sclerosis (MS) have been around for years, it's understandable that when something new is approved, people want to try it. So, just how serious a stumbling block is the price gap between old and new proving to be for payers in the US and EU? Are pharma's pricing justifications believed and accepted? ...Read More >>>
Published:
2018-01-01
Published by: FirstWord Pharma
Prices Starting From:
$2019
Payer attitudes to Orphan Drug pricing
Payer Attitudes to Orphan Drug FundingThe explosion of orphan drugs across Europe and the US is pushing healthcare finances towards breaking point according to payers. Requests for orphan drug designation have reached unprecedented levels and the high cost of these specialist treatments is swallowing up a larger and larger share of the drug funding pot. Payers are not happy and clearly something n...Read More >>>
Published:
2017-08-01
Published by: FirstWord Pharma
Prices Starting From:
$1908
Innovations in Drug Pricing and Reimbursement (2016)
IntroductionIs the drug pricing bubble about to burst?Drug costs are becoming unaffordable and draconian cost containment strategies are being employed.The pharma industry is winning few friends when it comes to drug pricing. Public, health professional, political and payer hostility is growing worldwide as the prices of new drugs for chronic disease, specialty medicines and even generics grow ex...Read More >>>
Published:
2016-02-01
Published by: FirstWord Pharma
Prices Starting From:
$1866
Trends and Innovations in Drug Pricing
IntroductionFirstWord’s Trends and Innovations in Drug Pricing report dissects international trends and examines how long-standing dynamics in competitive pricing and access will strengthen the payer position in demanding discounts in return for guaranteed patient access. Up-to-the-minute and based on the most current research and expert interviews, Trends and Innovations in Drug Pricing is an o...Read More >>>
Published:
2015-01-01
Published by: FirstWord Pharma
Prices Starting From:
$591
Tiered Pricing Strategies in Emerging Markets
IntroductionFor the pharmaceutical industry, emerging markets are dynamic, full of potential and offer solid growth at a time when established markets are contracting. But they also pose a significant problem: extreme disparities in income. Increasingly, companies are turning to tiered pricing as a solution. The strategy targets market segments, boosts market share and increases patient access to ...Read More >>>
Published:
2012-02-01
Published by: FirstWord Pharma
Prices Starting From:
$591